Advertisement

UDP-GlcNAc: Beta-Gal Beta1,3-N-Acetylglucosaminyltransferase 6 (B3GNT6) (Core 3 Synthase, C3GnT)

  • Akira Togayachi
  • Hisashi Narimatsu
Reference work entry

Abstract

Mucins, which are highly glycosylated with O-linked (mucin-type) glycans, are an essential component of mucinous glycoproteins secreted from the mucosal tissue of the esophagus, stomach, and intestine. Mucin-type glycoproteins have clusters of O-glycans whose synthesis is initiated by various UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases (pp-GalNAcTs). After the addition of a GalNAc residue to a serine and/or threonine residue by pp-GalNAcT, sugar residues are sequentially transferred to GalNAc on the peptide to form O-glycans. These O-glycans can be classified into several different groups according to their core structures. As illustrated in Fig. 30.1, there are at least seven core types. Each core structure is differentially expressed in conjunction with the differentiation and malignant transformation of various cells and tissues. The expression of core 3, GlcNAcβ1-3GalNAcα-serine/threonine, is limited to mucins from specialized tissues such as colon. Core 3 O-glycan, an important precursor in the biosynthesis of mucin-type glycoproteins, is synthesized by UDP-N-acetylglucosamine: GalNAc-peptide β1,3-N acetylglucosaminyltransferase(β3GnT; core 3 synthase, C3GnT).

Keywords

Familial Adenomatous Polyposis Acceptor Substrate Normal Colon Tissue Mucinous Glycoprotein GalNAc Residue 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Ahmed I, Chandrakesan P, Tawfik O, Xia L, Anant S, Umar S (2012) Critical roles of Notch and Wnt/beta-catenin pathways in the regulation of hyperplasia and/or colitis in response to bacterial infection. Infect Immun 80:3107–3121PubMedCentralPubMedCrossRefGoogle Scholar
  2. An G, Wei B, Xia B, McDaniel JM, Ju T, Cummings RD, Braun J, Xia L (2007) Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med 204:1417–1429PubMedCentralPubMedCrossRefGoogle Scholar
  3. Brockhausen I (1999) Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1473:67–95PubMedCrossRefGoogle Scholar
  4. Iwai T, Inaba N, Naundorf A, Zhang Y, Gotoh M, Iwasaki H, Kudo T, Togayachi A, Ishizuka Y, Nakanishi H, Narimatsu H (2002) Molecular cloning and characterization of a novel UDP-GlcNAc: GalNAc-peptide β1,3-N-acetylglucosaminyltransferase (β3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans. J Biol Chem 277:12802–12809PubMedCrossRefGoogle Scholar
  5. Iwai T, Kudo T, Kawamoto R, Kubota T, Togayachi A, Hiruma T, Okada T, Kawamoto T, Morozumi K, Narimatsu H (2005) Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc Natl Acad Sci U S A 102:4572–4577PubMedCentralPubMedCrossRefGoogle Scholar
  6. Kim YS (1998) Mucin glycoproteins in colonic neoplasia. Keio J Med 47:10–18PubMedCrossRefGoogle Scholar
  7. Lee SH, Hatakeyama S, Yu SY, Bao X, Ohyama C, Khoo KH, Fukuda MN, Fukuda M (2009) Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex. J Biol Chem 284:17157–17169PubMedCrossRefGoogle Scholar
  8. Lillehoj EP, Hyun SW, Kim BT, Zhang XG, Lee DI, Rowland S, Kim KC (2001) Muc1 mucins on the cell surface are adhesion sites for Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 280:L181–187PubMedGoogle Scholar
  9. Podolsky DK (1985) Oligosaccharide structures of human colonic mucin. J Biol Chem 260:8262–8271PubMedGoogle Scholar
  10. Porchet N, Buisine MP, Desseyn JL, Moniaux N, Nollet S, Degand P, Pigny P, Van Seuningen I, Laine A, Aubert JP (1999) MUC genes: a superfamily of genes? Towards a functional classification of human apomucins. J Soc Biol 193:85–99PubMedGoogle Scholar
  11. Slomiany A, Zdebska E, Slomiany BL (1984a) Structures of the neutral oligosaccharides isolated from A-active human gastric mucin. J Biol Chem 259:14743–14749PubMedGoogle Scholar
  12. Slomiany BL, Zdebska E, Slomiany A (1984b) Structural characterization of neutral oligosaccharides of human H + Leb + gastric mucin. J Biol Chem 259:2863–2869PubMedGoogle Scholar
  13. Snyder JD, Walker WA (1987) Structure and function of intestinal mucin: developmental aspects. Int Arch Allergy Appl Immunol 82:351–356PubMedCrossRefGoogle Scholar
  14. Thomsson KA, Holmen-Larsson JM, Angstrom J, Johansson ME, Xia L, Hansson GC (2012) Detailed O-glycomics of the Muc2 mucin from colon of wild-type, core 1- and core 3-transferase-deficient mice highlights differences compared with human MUC2. Glycobiology 22:1128–1139PubMedCrossRefGoogle Scholar
  15. Togayachi A, Sato T, Narimatsu H (2006) Comprehensive enzymatic characterization of glycosyltransferases with a β3GT or β4GT motif. Methods Enzymol 416:91–102PubMedCrossRefGoogle Scholar
  16. Williams SJ, McGuckin MA, Gotley DC, Eyre HJ, Sutherland GR, Antalis TM (1999) Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res 59:4083–4089PubMedGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  1. 1.Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology (AIST)TsukubaJapan

Personalised recommendations